Skip to main content
Fig. 5 | BMC Nephrology

Fig. 5

From: Continuous venovenous hemodiafiltration versus standard medical therapy for the prevention of rhabdomyolysis-induced acute kidney injury: a retrospective cohort study

Fig. 5

Comparison of biochemical indicators before and after the first continuous venovenous hemodiafiltration (CVVHDF) treatment in the CVVHDF + SMT group. CVVHDF + SMT group, received CVVHDF combined with standard medical therapy. Mb, myoglobin; CK, creatine kinase; Cr, creatinine; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; CO2-cp, carbon dioxide combining power; AG, anion gap; WBC, white blood cell; HGB, hemoglobin

Back to article page